Potential correlation, low vitamin D and increased risk of infection with SARS-CoV-2

People with low levels of Vitamin D may be more likely to catch coronavirus and die from COVID-19 infection, study suggests

 

  • Study compared average vitamin D levels in a country with coronavirus mortality
  • Found a link showing low vitamin D levels are associated with a higher death rate
  • Researchers ‘believe they can advise vitamin D supplementation’ to protect against the coronavirus

A preliminary study has found tentative evidence suggesting low levels of vitamin D may make it more likely an individual will die after contracting coronavirus. The research compared average levels of vitamin D across 20 European countries with COVID-19 infection rate and mortality. It revealed a convincing correlation where countries with low vitamin D levels were also the countries with highest mortality and COVID-19 infection rates. NN: We have long recommended that you Vitamin UP. And the fact that vitamin D is a great immune system booster. We were so convinced that we had compounded our special supplement The CoronaVit that had the right combination of ingredients, in the right form to maximize absorption. So all I can say is take your vitamins.

Click here to order Immune System booster Vitamins

The new omicron BA2 mutation is more contagious and will be more infectious

  • Danish scientists confirmed this week that the new subvariant can reinfect people who’ve previously had omicron, although it doesn’t appear to be all that common.
  • They also agree that it’s more contagious than the original version of omicron, BA.1, which is still widely circulating around the world.
  • But it’s surprisingly not driving a second wave of omicron infections. Globally, Covid cases have plunged 21% over the past week.

Continue reading “The new omicron BA2 mutation is more contagious and will be more infectious”

U.S. FDA considers approving a second COVID-19 booster shot

(Reuters) -U.S. health regulators are looking at authorizing a potential fourth dose of a COVID-19 vaccine in the fall, the Wall Street Journal reported on Saturday, citing sources familiar with the matter. The Food and Drug Administration has been reviewing data to authorize a second booster dose of the messenger RNA vaccines from Pfizer Inc and partner BioNTech SE and vaccines from Moderna Inc, the report added. The agency last month cut the interval to get a booster dose of COVID-19 vaccines from Pfizer and BioNTech as well as from Moderna, in a bid to provide better protection sooner against the Omicron variant. The planning is still in early stages, and authorization would depend on determinations as to whether the second booster should be authorized for all adults or particular age groups, and whether it should target the Omicron variant or be formulated differently, the report said. It added that no decision was final and that it could be necessary to make booster shots available earlier if a new variant appears. The United States reported 2,323 COVID-19 deaths on Friday, bringing the total count to 936,523. NN: It is settled business typical of these types of vaccines like the flue Jap the vaccine wears off very quickly. In the case of the covid vaccines studies show in 4 to 5 months protection drops dramatically Say you get your booster shot in March. That means your timing would be right to receive the modified to new variants that should be available in August or September. Thats when it looks like the new subvariant BA.2 starts infecting people in mass. For the record its a mistake to open things all the way. Have we not learned anything. Every time they open things up within 6 months another wave is upon us. The BA,2 variant is now dominate in South Africa, India, England and Denmark. A recent Denmark study finds its 30% more infectious than the current variant.an it infects more fully vaccinated people then any other variant. This is very early data.

Meet your new monster the BA.2 Omicron subvarient

https://youtu.be/PoxC0FQGqFQ

(CNN)The BA.2 virus — a subvariant of the Omicron coronavirus variant — isn’t just spreading faster than its distant cousin, it may also cause more severe disease and appears capable of thwarting some of the key weapons we have against Covid-19, new research suggests. New lab experiments from Japan show that BA.2 may have features that make it as capable of causing serious illness as older variants of Covid-19, including Delta. And like Omicron, it appears to largely escape the immunity created by vaccines. A booster shot restores protection, making illness after infection about 74% less likely. BA.2 is also resistant to some treatments, including sotrovimab, the monoclonal antibody that’s currently being used against Omicron. The findings were posted Wednesday as a preprint study on the bioRxiv server, before peer review. Normally, before a study is published in medical journal, it is scrutinized by independent experts. Preprints allow research to be shared more quickly, but they are posted before that additional layer of review.

Continue reading “Meet your new monster the BA.2 Omicron subvarient”

Worst yet to come Omicron is evading vaccines

Omicron is widely known to be more contagious than previous Covid strains. Scientists believe the worst of the virus may not yet be over. In a highly secure clean room at the University of NSW’s Kirby Institute, experts studied the strain at the beginning of Australia’s Omicron wave in mid-December and found out just how adept the variant is at evading vaccines. While the Delta variant was 60 per cent better at evading antibodies than the original virus found in Wuhan – even in the bodies of the double-vaxxed, Omicron was 16.5 times better at evading immunity – 10 times more than Delta. That explains why Omicron surged so quickly when it arrived in Australia – going from 110,000 active cases nationwide on Dec. 30 to 835,000 on Jan. 17. It has since eased significantly, with numbers dropping around 80 per cent since. But while the Omicron wave is subsiding across the globe, scientists believe new variants may continue to emerge for years – particularly in winter. Research from the Kirby Institute shows exactly how much more adept Omicron is at evading immunity via two vaccines or prior infection (pictured). A booster provides more protection Continue reading “Worst yet to come Omicron is evading vaccines”

Moderna eyes COVID booster by August

BRUSSELS (Reuters) – An Omicron-specific booster could be ready by August, the CEO of U.S. biotech firm Moderna told Reuters, but the firm is still gathering clinical data to determine whether that vaccine would offer better protection than a new dose of the existing jab. Last month Moderna began clinical trials for a booster dose specifically designed to target Omicron but initial results from studies in monkeys show the Omicron-specific shot may not offer stronger protection than a new dose of the existing vaccine. Moderna chief executive Stephane Bancel said in an interview the company aimed to have a booster ready by August 2022, before next autumn when he said more vulnerable people may need it. Moderna’s vaccines use mRNA technology to provoke an immune response, similar to the shot developed by Pfizer/BioNTech.

“We believe a booster will be needed. I don’t know yet if it is going to be the existing vaccine, Omicron-only, or bivalent: Omicron and existing vaccine, two mRNA in one dose.”

He said a decision would be made in the coming months when clinical data becomes available. Bancel also confirmed that under the best-case scenario Moderna would have ready by August 2023 a so-called pan-vaccine which would protect simultaneously against COVID-19, flu and other respiratory diseases. He added that pricing for this vaccine under development would be “very similar” to that applied to the current vaccine. Moderna charges different prices for different regions of the world with a range between $15 and $37, according to UNICEF, a United Nations agency involved in the distribution of vaccines to poorer nations. NN: many people are delaying their 4th shot. It is because of bogus information being spread that their will be a booster in March with new RNA targeting the latest variants. That is just not true.Try August! If your last vaccine is more than 4 months old your protection has dropped. Lets face facts we are into a 4 times a year regiment. We are averaging 3 major new variants a year, The latest wave the Omicron variant has run its course. BUT unfortunately its just not that easy. Their are several variants that are warming up in the wings. Do not get all silly on me. Another wave is coming. The messaging has been dismal. Reality is the science is evolving like science is suppose to do. The reason the messaging keeps changing is simple. Their are new mutations and we learn more every day. Its the nature of the beast.

S. Korea: Daily virus cases at new record of 54,941 Germany: 7-day incidence rate at new record of 1474.3

SEOUL, Feb. 12, 2022 (BSS/Xinhua) – South Korea’s daily number of COVID-19 cases hit a record high amid the spread of the Omicron variant, the health
authorities said on Saturday. According to the Korea Disease Control and Prevention Agency (KDCA), the country reported 54,941 more cases of COVID-19 for the past 24 hours, raising the total number of infections to 1,294,205. The daily caseload was up from 53,926 in the previous day, hovering above 50,000 for the third consecutive day. The recent resurgence was driven by infections in the Seoul metropolitan area amid the rapid spread of the Omicron variant, which became a dominant strain here. Of the new cases, 13,189 were Seoul residents. The number of the newly infected people living in Gyeonggi province and the western port city of Incheon was 15,952 and 5,059 respectively. The virus spread also raged in the non-metropolitan region. The number of new infections in the non-capital areas was 20,628, or 37.6 percent of the total local transmission.Among the new cases, 113 were imported from overseas, lifting the total to 27,090. The number of infected people who were in a serious condition stood at 275, up four from the previous day. Thirty-three more deaths were confirmed, leaving the death toll at 7,045. The total fatality rate was 0.54 percent. The country has administered COVID-19 vaccines to 44,725,434 people, or 87.2 percent of the total population, and the number of the fully inoculated people was 44,207,093, or 86.1 percent of the population. The number of those who received booster jabs was 29,244,945 people, or 57.0 percent of the population.

Germany: 7-day incidence rate at new record of 1474.3

Germany’s seven-day incidence rate, which counts the number of people infected with COVID-19 per 100,000 inhabitants, came in at 1474.3 on Saturday, setting a new record high. The figure for new cases of the virus registered daily declined in comparison to the previous days, standing at 209,789. The tally of people that contracted the disease since the beginning of the pandemic thus rose to 12,219,501. Meanwhile, the count of deaths linked to COVID-19 went up by 198 in the previous 24 hours to 119,877.

Covid-Infected HIV Patient Developed Mutations, Study Shows

https://youtu.be/rOF-4Ka_qPI

The study adds to evidence that Covid-19 may mutate rapidly when harboured by immunosuppressed individuals such as those not taking medication to treat HIV, and this may lead to the development of new variants. The Beta variant, with which the patient in the study was infected, was discovered in SA, as was the Omicron variant. “This case, like others before, describes a potential pathway for the emergence of novel variants,” the scientists said, stressing it was a hypothesis. “Our experience reinforces previous reports that effective anti-retroviral treatment is the key to controlling such events.” SA has the world’s biggest HIV epidemic with 8.2-million of its 60-million people infected with the virus which weakens the immune system. The coronavirus harboured by the patient in the study developed at least 10 mutations on the spike protein, which allows it to bind with cells, and 11 other mutations, the scientists said. Some of the changes were common to those seen in the Omicron and Lambda variants while other were consistent with mutations that allow the virus to evade antibodies.

Omicron deaths in USA EXCEED DELTA PEAK

More signs emerged that the Omicron wave is taking a less serious human toll in Europe than earlier phases of the pandemic as U.S. data showed daily average deaths from the disease exceeding the peak reached during the surge driven by the previously dominant Delta variant. In the U.S., the seven-day average for newly reported Covid-19 deaths reached 2,258 a day on Tuesday, up about 1,000 from daily death counts two months ago, data from Johns Hopkins University show. That is the highest since February 2021 as the country was emerging from the worst of last winter’s wave. While there is a large body of evidence suggesting that Omicron is less likely to kill the people it infects, it spreads much more quickly and therefore infects many more people than earlier variants, epidemiologists say. Continue reading “Omicron deaths in USA EXCEED DELTA PEAK”